Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention1: Carticosteroid injection with electroacupuncture: 1 ml Triamcinolone Acetonide (10 mg/ml) (Kenacort- A 10) with 1 ml Lignocaine (1%) [Corticosteroid injection] will be administered into
Sponsors
Prince Sattam Bin Abdulaziz University Al Kharj Saudi Arabia
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of the mild or moderate stage of CTS (according to criteria by Whitney and McDonnell) by an orthopedist or neurologist, symptom duration for more than three months, and general good health.
Exclusion criteria
Exclusion criteria: Advanced CTS, secondary CTS, any previous surgery in the upper limb, previous steroid injections and any physical therapy treatment within six months before the study, pregnancy, cervical radiculopathy, peripheral polyneuropathy, or other neurological conditions. Patients who underwent surgical treatment will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain intensity â?? VAS 2. Ultra sound analysis - 3. Functional disability - Boston Questionnaire 4. Hand grip â?? Hand dynamometer Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Kinesiophobia â?? Tampa scale 2. Depression â?? Hospital anxiety and depression scale 3. Quality of life â?? Euro Qol EQ-5D Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months | — |
Countries
Saudi Arabia
Contacts
Public ContactGopal Nambi
Prince Sattam Bin Abdulaziz University, Al- Kharj, Saudi Arabia.
Outcome results
None listed